Charmacy Pharmaceutical Co (HKSE:02289) Research & Development: HK$0 Mil (TTM As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02289 Charmacy Pharmaceutical Co Ltd HKSE:02289
76 GF Score
Price HK$5.50
GF Value HK$8.38
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Charmacy Pharmaceutical Co Research & Development?

Charmacy Pharmaceutical Co HKSE:02289 76 Research & Development is HK$0 Mil as of Dec. 2025. GuruFocus rates HKSE:02289 with a GF Score™ of 76/100 and a GF Value™ of HK$8.38 (Possible Value Trap). The stock has 3 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Charmacy Pharmaceutical Co's Research & Development for the six months ended in Dec. 2025 was HK$0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was HK$0 Mil.

Charmacy Pharmaceutical Co  (HKSE:02289) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Charmacy Pharmaceutical Co Research & Development Related Terms

Charmacy Pharmaceutical Co Research & Development Historical Data

* Premium members only.

The historical data trend for Charmacy Pharmaceutical Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Charmacy Pharmaceutical Co Research & Development Chart

Charmacy Pharmaceutical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Charmacy Pharmaceutical Co Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
HKSE:02289
76GF Score
Charmacy Pharmaceutical Co Ltd HKSE:02289
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Charmacy Pharmaceutical Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was HK$0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of HK$0 Mil mean?
Charmacy Pharmaceutical Co (HKSE:02289) has a Research & Development of HK$0 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Charmacy Pharmaceutical Co and its competitors.
Is Charmacy Pharmaceutical Co's Research & Development too high?
Charmacy Pharmaceutical Co's current Research & Development is HK$0 Mil. Overall, Charmacy Pharmaceutical Co has a GF Score™ of 76/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Charmacy Pharmaceutical Co's Research & Development compare to MCK and COR?
Charmacy Pharmaceutical Co's Research & Development of HK$0 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Medical Distribution company?
A good Research & Development depends on the Medical Distribution industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Charmacy Pharmaceutical Co and its competitors. Charmacy Pharmaceutical Co's current Research & Development is HK$0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Charmacy Pharmaceutical Co stock overvalued right now?
Based on GuruFocus' analysis, Charmacy Pharmaceutical Co (HKSE:02289) is currently considered Possible Value Trap. The stock's GF Value™ is HK$8.38, compared to a current price of HK$5.50 — trading 34.4% below its estimated fair value. The current Research & Development is HK$0 Mil. Charmacy Pharmaceutical Co's overall GF Score™ is 76/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Charmacy Pharmaceutical Co (HKSE:02289), the current Research & Development is HK$0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Charmacy Pharmaceutical Co (HKSE:02289) Overvalued in 2026?

Based on GuruFocus' analysis, Charmacy Pharmaceutical Co stock appears to be undervalued. The current stock price of HK$5.50 is trading 34.4% below its estimated GF Value™ of HK$8.38. GuruFocus considers Charmacy Pharmaceutical Co to be Possible Value Trap.

Key valuation signals for HKSE:02289:

  • Research & Development: HK$0 Mil
  • GF Value™: HK$8.38 vs. price of HK$5.50 (34.4% below fair value)
  • GF Score™: 76/100 with 3 warning signs

No single metric tells the full story. See the HKSE:02289 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Charmacy Pharmaceutical Co Business Description

Address No. 235, Song Shan North Road, Longhu District, Guangdong Province, Shantou, CHN, 515041
Charmacy Pharmaceutical Co Ltd operates within the pharmaceutical distribution industry, with a primary focus on the distribution of pharmaceutical products. The principal business activities encompass the wholesale of pharmaceuticals and related services, along with road transportation and cargo warehousing. The company's distribution network covers Southern China and surrounding areas including Fujian province. All the group's operations are located in China.
76GF Score

Get the complete analysis for HKSE:02289

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$5.50
Price
HK$8.38
GF Value